Anest. intenziv. Med. 2015;26(1):23-28

A concealed cause of hypotension - case resporIntesive Care Medicine - Case Report

Karvunidis Thomas*, Danihel Vojtěch, Chvojka Jiří, Ledvinová Lenka, Raděj Jaroslav, Novák Ivan, Matějovič Martin
JIP, I. Interní klinika FN Plzeň a LF v Plzni Univerzity Karlovy v Praze

The case report presents a rare case of repeated paroxysms of significant hypotension with other clinical signs of systemic illness and discusses appropriate diagnostic methods and therapeutic management.

Keywords: hypotension; mastocytosis; echocardiography; left ventricular outflow tract dynamic obstruction

Received: September 2, 2014; Accepted: November 20, 2014; Published: February 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karvunidis T, Danihel V, Chvojka J, Ledvinová L, Raděj J, Novák I, Matějovič M. A concealed cause of hypotension - case respor. Anest. intenziv. Med. 2015;26(1):23-28.
Download citation

References

  1. Akin, C., Metcalfe, D. D. Systemic mastocytosis. Annu. Rev. Med., 2004, 55, p. 419-432. Go to original source... Go to PubMed...
  2. Garcia-Montero, A. C., Jara-Acevedo, M., Teodosio, C. et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood, 2006, 108, p. 2366-2372. Go to original source... Go to PubMed...
  3. Akin, C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn., 2006, 8, p. 412-419. Go to original source... Go to PubMed...
  4. Fuller, S. J. New insights into the pathogenesis, diagnosis, and management of mastocytosis. Hematol. Oncol. Clin. North. Am., 2012, 26, p. 1143-1168. Go to original source... Go to PubMed...
  5. Verstovsek, S. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur. J. Haematol., 2013, 90, p. 89-98. Go to original source... Go to PubMed...
  6. Sperr, W. R., Valent, P. Diagnosis, progression patterns and prognostification in mastocytosis. Expert. Rev. Hematol., 2012, 5, p. 261-274. Go to original source... Go to PubMed...
  7. Pardanani, A. Systemic mastocytosis: disease overview, pathogenesis, and treatment. Hematol. Oncol. Clin. North Am., 2012, 26, p. 1117-1128. Go to original source... Go to PubMed...
  8. Schwartz, L. B., Irani, A. M. Serum tryptase and the laboratory diagnosis of systemic mastocytosis. Hematol. Oncol. Clin. North Am., 2000, 14, p. 641-657. Go to original source... Go to PubMed...
  9. Butterfield, J. H., Weiler, C. R. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int. Arch. Allergy Immunol., 2008, 147, p. 338-343. Go to original source... Go to PubMed...
  10. Akin, C., Valent, P., Metcalfe, D. D. Mast cell activation syndrome: Proposed diagnostic criteria. J. Allergy Clin. Immunol., 2010, 126, p. 1099-1104. Go to original source... Go to PubMed...
  11. Valent, P., Akin, C., Arock, M. et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int. Arch. Allergy Immunol., 2012, 157, p. 215-225. Go to original source... Go to PubMed...
  12. Chockalingam, A., Tejwani, L., Aggarwal, K. et al. Dynamic left venticular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence. Circulation, 2007, 116, p. 110-113. Go to original source... Go to PubMed...
  13. Bybee, K. A., Prasad, A. Stress-related cardiomyopathy syndromes. Circulation, 2008, 118, p. 397-409. Go to original source... Go to PubMed...
  14. El Mahmoud, R., Mansencal, N., Pilliere, R. et al. Prevalence and characteristics of left ventricular outflow tract obstruction in Tako-Tsubo syndrome. Am. Heart J., 2008, 156, p. 543-548. Go to original source... Go to PubMed...
  15. Chockalingam, A., Xie, G. Y. Echocardiography in stress cardiomyopathy and acute LVOT obstruction. Int. J. Cardiovasc. Imaging, 2010, 26, p. 527-535. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.